MENU
+Compare
TRUMY
Stock ticker: OTC
AS OF
Dec 26 closing price
Price
$14.64
Change
-$0.04 (-0.27%)
Capitalization
21.7B

TRUMY Terumo Corp. Forecast, Technical & Fundamental Analysis

Started as a clinical thermometer producer in Japan in 1921, Terumo is a comprehensive medical device player with a diversified global revenue... Show more

TRUMY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for TRUMY with price predictions
Dec 26, 2025

Momentum Indicator for TRUMY turns negative, indicating new downward trend

TRUMY saw its Momentum Indicator move below the 0 level on December 08, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 94 similar instances where the indicator turned negative. In of the 94 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 53 cases where TRUMY's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TRUMY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for TRUMY entered a downward trend on December 26, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where TRUMY's RSI Indicator exited the oversold zone, of 38 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for TRUMY just turned positive on December 18, 2025. Looking at past instances where TRUMY's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.346) is normal, around the industry mean (9.433). P/E Ratio (25.822) is within average values for comparable stocks, (167.041). Projected Growth (PEG Ratio) (2.173) is also within normal values, averaging (2.561). Dividend Yield (0.013) settles around the average of (0.017) among similar stocks. P/S Ratio (3.177) is also within normal values, averaging (112.112).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. TRUMY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TRUMY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
TRUMY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

TRUMY is expected to report earnings to 15 cents per share on February 05

Terumo Corp. TRUMY Stock Earnings Reports
Q4'25
Est.
$0.15
Q3'25
Missed
by $0.01
Q2'25
Beat
by $0.02
Q1'25
Missed
by $0.05
Q4'24
Missed
by $0.01
The last earnings report on November 12 showed earnings per share of 15 cents, missing the estimate of 16 cents. With 211.55K shares outstanding, the current market capitalization sits at 21.70B.
A.I.Advisor
published Dividends

TRUMY paid dividends on July 12, 2024

Terumo Corp. TRUMY Stock Dividends
А dividend of $0.14 per share was paid with a record date of July 12, 2024, and an ex-dividend date of March 27, 2024. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
2-44-1 Hatagaya
Phone
+81 333748111
Employees
26482
Web
https://www.terumo.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
LTCN5.990.03
+0.50%
Grayscale Litecoin Trust (LTC)
ESGV122.600.12
+0.10%
Vanguard ESG US Stock ETF
TRPA39.060.01
+0.03%
Hartford AAA CLO ETF
ISHG75.39-0.06
-0.08%
iShares 1-3 Year International TrsBd ETF
TBJL19.94-0.04
-0.22%
Innovator 20+ Year Tsy Bd Bfr ETF July

TRUMY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TRUMY has been loosely correlated with HOCPY. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if TRUMY jumps, then HOCPY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRUMY
1D Price
Change %
TRUMY100%
-0.27%
HOCPY - TRUMY
51%
Loosely correlated
-0.16%
SSMXY - TRUMY
45%
Loosely correlated
-1.01%
SMTI - TRUMY
43%
Loosely correlated
-1.22%
OLYMY - TRUMY
40%
Loosely correlated
+0.20%
AZTA - TRUMY
39%
Loosely correlated
+0.70%
More

Groups containing TRUMY

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRUMY
1D Price
Change %
TRUMY100%
-0.27%
Pharmaceuticals: Other
industry (102 stocks)
24%
Poorly correlated
-0.62%
Pharmaceuticals
industry (375 stocks)
20%
Poorly correlated
-0.12%